Abstract
Health risks from particles are a priority challenge to health protection at work. Despite the ubiquitous exposure to a wide range of particles and the many years of research in this field, there are fundamental unresolved questions regarding the prevention of particle-related respiratory diseases. Here, the highly relevant particulate material silicon dioxide was analyzed with emphasis on defined size and shape. Silica particles were prepared with different size and shape: Spheres (NS nanospheres 60 nm; SMS submicrospheres 230 nm; MS microspheres 430 nm) and rods (SMR submicrorods with d = 125 nm, L = 230 nm; aspect ratio 1:1.8; MR microrods with d = 100 nm, L = 600 nm; aspect ratio 1:6). After an in-depth physicochemical characterization, their effects on NR8383 alveolar macrophages were investigated. The particles were X-ray amorphous, well dispersed, and not agglomerated. Toxic effects were only observed at high concentrations, i.e. ≥ 200 µg mL−1, with the microparticles showing a stronger significant effect on toxicity (MS≈MR > SMR≈SMS≈NS) than the nanoparticles. Special attention was directed to effects in the subtoxic range (less than 50% cell death compared to untreated cells), i.e. below 100 µg mL−1 where chronic health effects may be expected. All particles were readily taken up by NR8383 cells within a few hours and mainly found associated with endolysosomes. At subtoxic levels, neither particle type induced strongly adverse effects, as probed by viability tests, detection of reactive oxygen species (ROS), protein microarrays, and cytokine release (IL-1β, GDF-15, TNF-α, CXCL1). In the particle-induced cell migration assay (PICMA) with leukocytes (dHL-60 cells) and in cytokine release assays, only small effects were seen. In conclusion, at subtoxic concentrations, where chronic health effects may be expected, neither size and nor shape of the synthesized chemically identical silica particles showed harmful cell-biological effects.
Subject terms: Environmental sciences, Nanoscience and technology
Introduction
Silica is the oxide of silicon, i.e. SiO2. If prepared by wet-chemical synthesis, it is usually X-ray amorphous and can be represented by the general formula SiO2·x H2O (amorphous silica or polysilicic acid). Several anhydrous and crystalline forms are also known, with quartz (stoichiometric SiO2) being the most prominent1. In combination with other metal oxides, crystalline silicates form the biggest part of the earth's crust, and are almost ubiquitous. Silica particles (usually in the X-ray amorphous form) have many applications, e.g. in food or consumer products, as well as in biomedicine for potential therapeutic applications like gene and protein delivery and optical imaging2−4. Due to favorable properties like colloidal and chemical stability, the possibility for a covalent surface modification, and a high specific surface area, the application cases for silica particles and silica-based materials have grown rapidly5−8. Still, the development and synthesis of silica particles with precisely controlled physicochemical properties like shape, particle size distribution, and surface charge are critical steps for their toxicological evaluation and also for their use for biomedical application7,9−17.
Silica (nano-)particles are also of high importance in food and consumer products1,18. Although silica is considered to be non-toxic after oral intake18, it can cause inflammatory effects after inhalation6,19−22. Continuously high levels of inhalative particle exposure, including silica, lead to a chronic inflammation of the lung, characterized by the accumulation of inflammatory cells, in particular alveolar macrophages and neutrophil granulocytes23. Chronic inflammation can lead to fatal lung dysfunction, including chronic obstructive pulmonary disease (COPD), fibrosis (such as silicosis and asbestosis), and cancer21,24−30. Crystalline silicon dioxide (like quartz) appears to be more harmful than amorphous silica, possibly due to its different surface nature and lower water content8,18,21,29,31.
Although there is extensive literature on the biological effects of silica particles, most studies are difficult to compare because of different particle properties like size, shape, charge or surface functionalization27,32. Usually, the cell types challenged with silica particles are also different which makes a comparison difficult14,18,27,33. Thus, there is no consensus about the different and potentially adverse biological effects of silica26. Furthermore, only few methods have been described for the preparation of monodisperse rod-shaped silica particles without templates or polymer additives, being present in well-dispersed and not agglomerated form.
Thus, our aim was to prepare silica particles with different shape (spheres and rods) and different size from nano- to microscale, but with identical surface chemistry. Five morphologically different but chemically uniform silica samples were synthesized and characterized, i.e. all parameters were kept constant except for particle size and shape. Special emphasis was laid on the inflammatory potential in the subtoxic concentration range (particle concentration which provoked less than 50% cell death compared to the untreated cell control) which is less frequently investigated, but may have strong effects in a persistent long-term exposition, e.g. promote a chronic inflammation. As the chemo-attraction of neutrophils is a key event in inflammation, the particle-induced migration of neutrophils is suggested as a functional and predictive in vitro model for the mechanistic investigation of a particle-induced inflammation of the lung34−36.
Results
The first synthesis of monodisperse spherical silica particles with a narrow size distribution was reported by Stöber et al.37. Based on this method, many modifications to synthesize silica particles in the size range of 50 nm to 1 µm by the hydrolysis of tetraethyl orthosilicate (TEOS) in the presence of ammonia have been published. Particle size and shape can be adjusted by the choice of additives5,9,38. We prepared spherical particles with three different diameters (denoted here as nanospheres NS: 60 nm, submicrospheres SMS: 230 nm, and microspheres MS: 430 nm) by variations of the Stöber method39. The particle size was controlled by changing the molar ratios of the reagents in the reaction mixture (TEOS, water and ammonia) and performing syntheses at different temperatures (25 °C, 47 °C, 68 °C). For the synthesis of rod-shaped silica particles with different lengths (denoted here as submicrorods SMR: 125 nm·230 nm, and as microrods MR: 100 nm·600 nm), the cationic surfactant CTAB was used to induce a rod-shaped growth of the particles by modification of the Stöber process using the soft-template strategy39,40. We classified the particles as "nano", "submicro", and "micro" for the sake of simplicity for the following discussion. For microscopic cell uptake studies, all synthesized silica particles were fluorescently labeled with fluorescein isothiocyanate-functionalized polyethyleneimine (PEI-FITC). All syntheses were multiply carried out and very robust in terms of reproducibility.
The particles were characterized by scanning electron microscopy (SEM), dynamic light scattering (DLS), UV/vis spectroscopy, infrared (IR) spectroscopy and X-ray powder diffraction (XRD). All physicochemical data are summarized in Table 1.
Table 1.
Size by SEM/nm | Size by DLS/nm | PDI from DLS | Zeta potential by DLS/mV | Size by DLS/nm | PDI from DLS | Zeta potential by DLS/mV | Particle number per g solid | Specific surface area/m2 g−1 | |
---|---|---|---|---|---|---|---|---|---|
Unfunctionalized | Coated with PEI | ||||||||
Nanospheres | 60 | 117 | 0.22 | − 16 | 222 | 0.32 | + 29 | 4.42 × 1015 | 50 |
Submicrospheres | 230 | 272 | 0.08 | − 53 | 360 | 0.21 | + 36 | 7.85 × 1013 | 13 |
Submicrorods | 125·230 | 357 | 0.23 | − 29 | 423 | 0.38 | + 22 | 2.77 × 1014 | 22 |
Microspheres | 430 | 519 | 0.15 | − 28 | 582 | 0.19 | + 39 | 1.20 × 1013 | 7.0 |
Microrods | 100·600 | 439 | 0.32 | − 22 | 564 | 0.45 | + 28 | 1.06 × 1014 | 21 |
All particles were completely X-ray amorphous. The particle numbers and the specific surface area were computed from the SEM particle size data. DLS was performed in water at pH 7.
The size of the silica particles and their morphology were determined by SEM (Fig. 1). Scanning electron micrographs showed spherical and rod-like particles with a narrow particle size distribution. The corresponding histograms of the number-weighted particle diameters and lengths are shown in Fig. 2. From these data, geometric parameters and particle concentrations can be derived.
To investigate the colloidal stability and the particle size distribution, we performed DLS measurements (Fig. 3). The polydispersity index (PDI) was below 0.3 for all particles, indicating a low degree of agglomeration in the particle dispersions13. This is supported by the fact that the hydrodynamic diameter by DLS was only a little larger than the diameter of the solid core as determined by SEM. The zeta potential measurements at pH 7 in water showed that all unfunctionalized particles were negatively charged (due to deprotonation of surface silanol groups) whereas all PEI-coated particles carried a positive charge due to the cationic polyelectrolyte PEI.
X-ray powder diffraction showed that all silica particles were non-crystalline, i.e. fully amorphous (Fig. 3). Thus, we can exclude the presence of crystalline SiO2, i.e. the particles consist exclusively of hydrated silica in the form of SiO2·x H2O. The IR spectra showed characteristic Si–O stretching bands at 1082 to 1114 cm−141. For rod-like particles, the complete removal of CTAB (a potentially cytotoxic synthesis additive) was confirmed by IR spectroscopy (absence of C-H bands). For PEI-FITC-labeled particles, the UV/vis spectrum showed the expected absorption band at 495 nm (FITC).
The cell-to-particle contact plays a strong role for the biological effects42,43. When it comes to contact with cells, the colloidal stability (sedimentation rate) is of prime importance. We have therefore used an in vitro sedimentation, diffusion and dosimetry model (ISDD) to estimate the particle precipitation and diffusion both in water and in cell culture media (Fig. 4)44. Due to their high density, the microparticles will sediment rapidly onto the cells, whereas the nanoparticles remain in dispersion for a much longer time. Table 2 summarizes the concentration data at the subtoxic concentration of 100 µg mL−1.
Table 2.
Silica (SiO2) concentration/mmol L−1 | Silica particle concentration/L−1 | Silica particle surface/m2 per particle | Total silica particle surface/m2 L−1 | Total silica particle surface per well (640 µL)/m2 | Total silica particle surface per cell (48,000 cells)/µm2 | Total silica concentration after complete sedimentation in the well/particles m−2 | |
---|---|---|---|---|---|---|---|
Nanospheres | 1.7 | 4.42 × 1014 | 1.13 × 10−14 | 5.0 | 3.2 × 10−3 | 67,000 | 1.41 × 1015 |
Submicrospheres | 1.7 | 7.85 × 1012 | 1.66 × 10−13 | 1.3 | 8.3 × 10−4 | 17,000 | 2.51 × 1013 |
Submicrorods | 1.7 | 2.77 × 1013 | 8.01 × 10−14 | 2.2 | 1.4 × 10−3 | 29,000 | 8.86 × 1013 |
Microspheres | 1.7 | 1.20 × 1012 | 5.81 × 10−13 | 0.70 | 4.5 × 10−4 | 9,300 | 3.84 × 1012 |
Microrods | 1.7 | 1.06 × 1013 | 1.96 × 10−13 | 2.1 | 1.3 × 10−3 | 28,000 | 3.40 × 1013 |
As the cytotoxic effects of particles have been related to their total surface area, also with respect to the number of cells, the data were converted to different ratios (see discussion).
As typical cells of the immune system, NR8383 rat alveolar macrophages were used for cell culture experiments and incubated with silica particles in defined doses with different specific particle surface areas. These cells have also been proposed as models for particles to elucidate inhalation toxicity in in vitro assays32. The activity of particles in biological systems essentially depends on whether the particles can penetrate cells as well as on their subsequent intracellular fate. In general, particles can enter cells by various pathways which can be analyzed by different methods, such as confocal laser scanning microscopy (CLSM), fluorescence-activated cell sorting (FACS), or focused ion beam milling/scanning electron microscopy (FIB/SEM), depending on the cell type and the physicochemical properties of the nanoparticle43,45. The uptake of unfunctionalized silica particles by NR8383 macrophages as relevant cell type in particle contact23,27. After 24 h of incubation was analyzed in detail using cross-sectional analysis of single cells by FIB/SEM and subsequent TEM/EDX of FIB-prepared cell lamellae. Figure 5 shows representative SEM images after FIB cutting of macrophages incubated with spherical silica nanoparticles, submicroparticles, and microparticles. The particles were found as electron-dense structures inside the cells. Notably, neither size nor shape of the nanoparticles were changed by the uptake, however, the nanospheres were mainly present as larger agglomerates.
The chemical identity of the nanoparticles after uptake was demonstrated by TEM and corresponding EDX spectra of the cells (Fig. 6). EDX spectra showed signals for carbon (C), oxygen (O), and silicon (Si). The elements C and O were detected in all organic samples due to the presence of organic cell material as shown earlier for untreated hMSC (no exposure to particles)46. However, the silicon signal clearly confirms the presence of silica particles. As it is generally accepted, particles are taken up by mammalian cells by endo- and pinocytosis, depending on the cell type as well as on the particle properties, i.e. size, charge (zeta potential), shape, and functionalization43,47−53. Typically, particles are localized as agglomerates in membrane-enclosed vesicles within the cells. For silica nanoparticles of spherical and rod-like shape it has been shown that they were all taken up by macrophages, although the endocytosis pathway was dependent on the particle geometry54.
The localization of internalized silica particles inside NR8383 cells after 24 h of exposure was also assessed by CLSM with fluorescent PEI-FITC-labeled particles and LysoTracker Red DND-99, which allowed the labeling and tracking of acidic organelles like endosomes, lysosomes, and endolysosomes. The overlays of the PEI-FITC and LysoTracker signals revealed that all particle types were mainly associated with endo- and lysosomal structures (Fig. 7). It is well accepted that internalized particles mainly end up in endolysosomal compartments46,52,55−57.
The cytotoxic effects of the different silica particles on NR8383 cells at various particle concentrations were determined by propidium iodide (PI) staining of non-viable cells after 16 h of incubation (Fig. 8). In general, a concentration-dependent uptake of each particle type was observed (correlation coefficient > 0.86) as analyzed by flow cytometry (data not shown). A statistically significant cell toxicity was found for all silica particle morphologies (with nanospheres being the only exception) at high particle concentrations of 200 and 300 µg mL−1, while concentrations below 200 µg mL−1 had no significant effect on the cell viability except the available silica nanoparticles that served as positive control (agglomerated amorphous silica nanoparticles with an agglomerate size of 2000 ± 1000 nm)36. For these, a statistically significant effect on cytotoxicity was observed at 100 µg mL−1. Among the spherical silica particles, microspheres exhibited the highest toxicity, which was significantly enhanced compared to nanospheres and submicrospheres, indicating a size-dependent effect. Similarly, in the case of the rod-shaped particles the cell toxicity of microrods was significantly higher compared to submicrorods. In general, the cytotoxic concentrations agree with the literature on silica (nano-)particles1,8,18.
Reactive oxygen species (ROS) generated by NR8383 macrophages after 2 h of exposure to silica particles of different morphologies were detected by the dichlorofluorescein (DCF) assay (Fig. 9). Significantly enhanced ROS levels in comparison to untreated cells which can be associated with cell activation were detected for silica nanospheres, submicrospheres and submicrorods, similar to the positive control (3% H2O2 served as positive control). Silica microspheres and microrods did not affect ROS production. Cell activation was most pronounced for the submicroparticles (submicrospheres and submicrorods) and significantly enhanced compared to both nano- and microparticles.
The effects of different silica particles on the expression of bioactive factors by NR8383 macrophages were investigated with cell culture supernatants after 16 h of particle exposure (100 µg mL−1; subtoxic level) and a chemiluminescence-based protein microarray which allowed the simultaneous detection of 79 signaling molecules like cytokines, chemokines, and growth factors. Based on the proteomic repertoire of NR8383 cells as reported by Duhamel et al.58, 27 of the 79 detected factors were selected for a detailed analysis. The qualitative heat map in Fig. 10 showed the relative expression levels of the selected factors.
The factors IL-1β, GDF-15, TNF-α, and CXCL1 were selected for a detailed quantitative analysis by Sandwich-ELISA (Fig. 11). All silica particle types significantly enhanced the release of IL-1β, compared to an untreated control at a particle concentration of 200 µg mL−1, indicating an inflammatory response of the NR8383 cells. At this particle concentration, the GDF-15 release was also increased in the presence of microspheres and the rod-shaped submicro- and microparticles, whereas the TNF-α release was increased only by nanospheres and microrods. However, a silica concentration of 200 µg mL−1 was already associated with cytotoxicity (Fig. 8). At subtoxic particles concentrations of 100 µg mL−1, none of the silica particles induced a significant cell activation, except for the increased GDF-15 release in the presence of microspheres. Furthermore, the expression of the chemokine CXCL1 was not affected by any particle type. In addition, a particle size-dependent effect on the activation of NR8383 was not observed in this study.
The potential of chemotactic factors released from NR8383 cells to recruit leukocytes (dHL-60 cells) was finally analyzed by the PICMA (Fig. 12). There were only small effects of all kinds of silica particles compared to the positive control, and there was no significant difference between the particle types. Remarkably, the commercially acquired silica particles, which served as positive control, had a significantly higher effect than the newly synthesized silica particles.
Discussion
Usually, smaller silica nanoparticles have a higher cytotoxicity and a higher potential for the release of proinflammatory cytokines8,27. Chen et al. have reviewed the effect on the immune system and their interaction with the corresponding cells, including macrophages27. The specific surface area has been proposed as a major parameter for the cytotoxicity effects of silica nanoparticles8,32. The same was found for the genotoxicity with macrophages59.
We found only small differences between the five kinds of particles. Cytotoxic effects were only observed at high concentrations, i.e. ≥ 200 µg mL−1, with the microparticles being significantly more toxic (MS≈MR > SMR≈SMS≈NS) than the nanoparticles. In addition, our data on ROS formation showed that the sedimentation rate of particles (Fig. 4, particle-cell-contact) and the particle dose which is influenced by the size of the particles (the smaller the particles, the higher the dose in cell culture), probably influenced the formation of ROS. This in turn means that at a higher particle dose in cell culture (NS > SMS > MS) and a higher sedimentation rate (MS > SMS > NS) of silica particles, more ROS will be formed (Table 2). Table 3 gives a qualitative overview on the biological effects of the particles. Despite small differences, no particle type induced significant adverse effects on the cells in the subtoxic concentration range. Apparently, neither the particle size nor the particle shape play a significant role in contact with NR8383 macrophages or dHL-60 leukemia cells. However, differences in assay conditions may explain differences between published studies. It has been reported that the presence of serum within cell culture medium enhanced the polydispersity index and the hydrodynamic diameter of silica nanoparticles and led to decreased toxic effects33. However, is also not always clear in published studies whether the analyzed particles were agglomerated or dispersed.
Table 3.
Uptake by cells | Relative cytotoxicity | Reactive oxygen species | Cytokine induction (overall heat map) | IL-1β | GDF-15 | TNF-α | CXCL1 | PICMA | |
---|---|---|---|---|---|---|---|---|---|
Nanospheres | Yes | Low | Low | High | Low | Low | High | Low | Low |
Submicrospheres | Yes | Low | Intermediate | High | High | Low | Low | Low | Low |
Submicrorods | Yes | Intermediate | Intermediate | Low | High | High | Low | Low | Low |
Microspheres | Yes | High | Low | Intermediate | High | High | Low | Low | Low |
Microrods | Yes | High | Low | Low | High | High | High | Low | Low |
Silica positive control (agglomerated) | – | High | – | – | – | – | – | – | High |
All data are relative within the five particle types and the positive control.
While the biological effects of the newly synthetized silica particles differed only slightly from each other, the strongest particle-induced chemotaxis was caused by the commercially acquired silica nanoparticles, which served as positive control (Fig. 12). The characterization of these particles in a previous work36. showed a clear agglomeration with a particle size of 2000 ± 1000 nm that leads to a rapid sedimentation onto the cells. In the present study, the silica positive control was the only particle type that was clearly agglomerated. This observation is consistent with the hypothesis that stronger effects of nano-sized compared to micro-sized particles can be explained by the higher volume consumption of their agglomerates in the lysosomes of phagocytizing alveolar macrophages60,61.
The ISDD model gave the fractions of nano-, submicro-, and microspheres delivered to cells during 24 h in vitro with a medium height (liquid level) of 2.5 mm in the cell culture well. While the nanoparticles have a lower contact with the cells, both submicro- and microparticles sediment within hours. Due to the higher viscosity and density, the cell-particle contact was generally slower in medium than in pure water. Such differences in the gravitational settling of particles are a possible explanation why microparticles induced an enhanced toxic effect at high concentrations compared to the nanoparticles, consistent with the agglomerated silica positive control.
Wiemann et al. have reported extensive data on the NR8383 alveolar macrophages as in vitro model to assess the inhalation toxicity of particles32. In their studies, the particles had mostly sedimented onto the cells after 16 h, usually due to agglomeration. This was also the case for our particles, especially for the bigger ones (submicro and micro particles). They have classified "naked" silica particles (5 to 50 nm) as biologically active and ligand-coated silica particles as inactive. Wiemann et al. defined a threshold value of 4000 µm2 per cell for the distinction between active and passive materials. As shown in Table 2, these values are exceeded at 100 µg mL−1 for all our particles. Thus, we can conclude in line with Wiemann et al. that the observed effects were mostly due to particle overload and not to a particle-specific toxicity, in agreement with earlier opinions1,18. A significant cytotoxic effect of particle size or particle shape cannot be deduced from our data; the particles cause only low adverse effects.
Conclusions
Five different types of chemically identical silica particles without surface functionalization which differ only in size and shape were prepared. All particles were readily taken up by NR8383 alveolar macrophages. Cytotoxic effects were observed at 200 µg mL−1 and above, where the toxicity was probably dependent on the particle-cell-contact (MS > SMS > NS) and the formation of ROS probably by the sedimentation in addition to the particle dose, which is dependent on the size of the particles (the smaller the particles the higher the particle dose). In the subtoxic concentration range (100 µg mL−1), all particle types induced the expression of different cytokines. A more detailed analysis of four mainly pro-inflammatory cytokines showed mixed results with no clear differences between the particles. The particle-induced cell migration assay (PICMA) confirmed that all five types of silica particles have only low pro-inflammatory potential. We conclude that at least in this size range (between 60 and 600 nm, considering all particle types) neither particle size nor particle shape are significant parameters for cell-biological effects at subtoxic concentrations. In comparison to crystalline quartz, all samples investigated here consisted of amorphous hydrated silica. The lower toxicity in comparison to quartz may be due to the hydrated state of the surface in comparison to the oxidic and more ordered crystalline surface of quartz. Further studies are necessary to elucidate the difference between amorphous and crystallize SiO2 species.
Methods
Chemicals
We used tetraethyl orthosilicate (TEOS, Alfa Aesar, 98%), aqueous ammonia (NH3, 25–30%, Carl Roth), ethanol (p.a., Fisher Chemicals), cetyltrimethylammonium bromide (CTAB, Sigma-Aldrich, 99%), branched polyethyleneimine (PEI, Mw = 25,000 g mol−1, Sigma-Aldrich), and fluorescein-labeled polyethyleneimine (PEI-FITC, Mw = 25,000 g mol−1, Sigma-Aldrich) as obtained. All syntheses were carried out in ultrapure water (Purelab ultra instrument from ELGA). Prior to the syntheses, the glassware was cleaned first with boiling aqua regia and then twice with boiling water. The particles were isolated by centrifugation with a Heraeus Fresco 21 centrifuge (Thermo Scientific). All particles were endotoxin-free as analyzed by the Limulus Amebocyte Lysate test with a detection limit of < 0.01 EU mL−1 (Endosafe nexgen-PTS, Charles River)62.
Instruments
For dynamic light scattering for particle size analysis and zeta potential determination, we used a Malvern Zetasizer Nano ZS ZEN 3600 instrument (Malvern Panalytical Ltd.; 25 °C, laser wavelength 633 nm), operating at a fixed angle of 173° in backward scattering mode. The peak profile of the size distribution was analyzed by a log-normal distribution fit. The average particle diameter is given as mean value of the maximum of the size distribution from the log-normal distribution fit analysis and the empirical standard deviation as given by the instrument software.
Ultraviolet–visible spectroscopy (UV/vis) was carried out with a Varian Cary 300 instrument (Agilent Technologies, Inc.) in Suprasil micro quartz cuvettes with a sample volume of 750 µL after dilution and background correction.
Fourier-transformed infrared spectroscopy (FT-IR) was performed with an Attenuated Total Reflection (ATR) Bruker Alpha Platinum FT-IR spectrometer. FT-IR spectra of dried silica particles and pure CTAB were obtained by pressing them onto a diamond plate.
Confocal laser scanning microscopy was performed with a Zeiss LSM 700 instrument (Carl Zeiss Microscopy GmbH, Jena, Germany). Fluorescence images were taken (Zeiss LSM 700 microscope and Zen 2010 software) and digitally processed using Adobe Photoshop 7.
Flow cytometric analyses were carried out with an FACSCalibur flow cytometer (BD Bioscience, Heidelberg, Germany). For each measurement, 10,000 cells were analyzed and the data were quantified with the CELLQuest 1.2.2 software (BD Biosciences).
Scanning electron microscopy of the particles was performed with a microscope type FEI ESEM Quanta 400 FEG (ThermoFisher). Prior to the investigation, the samples were sputter-coated with a thin conductive AuPd 80:20 layer.
For X-ray powder diffraction, we isolated the nanoparticle dispersion, shock-froze it with liquid nitrogen, and lyophilized it at 0.31 mbar and − 10 °C in a Christ Alpha 2-4 LSC freeze-dryer. X-ray powder diffraction was carried out with a Bruker D8 ADVANCE (Bruker Corp.) diffractometer operating in Bragg–Brentano geometry with Cu Kα radiation (λ = 1.54 Å, 40 kV and 40 mA). As sample holder, a single-crystalline silicon sample holder with a crystallographic (911) plane to minimize background scattering was used.
The FIB system (type FEI Helios G4 CX) consisted of an electron column and an ion column. We used gallium as liquid metal ion source to produce cross-sections of cells at an acceleration voltage of 30 kV together with a stepwise current reduction from 22 to 2.7 nA. SEM images were recorded at an acceleration voltage of 5 kV. TEM imaging and EDX analysis were performed with a FEI Tecnai F20 instrument.
Synthesis of silica particles
Silica nanospheres, submicrospheres, and microspheres were obtained by a modified Stöber process, following the protocols described in the literature with some modifications39,40. For nanospheres, ammonia (13.2 mL, 25%) was added to ethanol (200 mL) at 68 °C under continuous stirring. After 30 min, TEOS (5.2 mL) was added to the mixture. The reaction was continued with stirring for 4 h at 68 °C, followed by stirring at room temperature for 12 h. The nanoparticles were isolated by centrifugation and redispersion in water (3,500 rpm, 90 min, three times), redispersed in ethanol, and dried in air at 200 °C for 3 h. For submicrospheres, the procedure consisted of mixing water (6.1 mL) and ammonia (2.8 mL, 30%) at 47 °C in ethanol (50 mL), followed by the addition of TEOS (6.2 mL) and stirring for 4 h. After 4 h, the reaction mixture was cooled to room temperature and stirred for another 16 h. The particles were isolated and purified as described above. Microspheres were synthesized by the following procedure: Ammonia (4.2 mL, 30%) and water (4.8 mL) were added to ethanol (50 mL) at room temperature under continuous stirring for 20 min. Then, TEOS (4.9 mL) was added and the mixture was stirred for another 16 h at room temperature. After synthesis, silica microspheres were collected by centrifugation (3,500 rpm, 30 min) and washed with ethanol several times.
Silica submicrorods and microrods were synthesized by a modified Stöber process according to Ref.63 with a modified molar ratios of the reagents. For the synthesis of silica submicrorods, CTAB (0.12 g) was dissolved in water (30 mL) and stirred at 30 °C for 30 min. After cooling the solution to room temperature, ammonia (0.3 mL, 25%) was added to the CTAB solution and stirred for 20 min. Then, TEOS (0.25 mL) was added and the reaction mixture was stirred for 1 h. After 7 min, the originally clear solution had assumed a turbid white color. For the synthesis of silica microrods, CTAB (0.3 g) was completely dissolved in water (40 mL) and stirred at 30 °C for 30 min. Ammonia (1 mL, 30%) was added. After 20 min, TEOS (1.8 mL) was added and stirring of the reaction mixture was continued at room temperature for 1 h. Silica submicrorods and microrods were collected by centrifugation (3500 rpm, 30 min) and washed with ethanol several times. In the next step, the particles were was redispersed in ethanol and heated at 60 °C for 6 h in an ethanolic HCl solution (EtOH:HCl = 0.99:0.01 v/v) to remove the organic surfactant (CTAB). The silica particles were purified by triple centrifugation (3500 rpm, 30 min) in ethanol and dried at 200 °C for 3 h. The quantitative absence of CTAB was shown by IR spectroscopy (Fig. 3).
The number of particles in 1 g solid was then computed from the average particle mass for spheres and rods:
with r the particle radius and L the particle length, both obtained by SEM (Table 1), and ρ the density of silica (2000 kg m3)63. The specific surface area of particles (m2 g−1) was calculated as follows:
Functionalization of silica particles with FITC-labeled polyethyleneimine (PEI-FITC)
The dried silica particles were surface-functionalized with FITC-labeled polyethyleneimine (4 µL, 1 g L−1) by stirring a particle dispersion in ethanol (2 g L−1) overnight at room temperature under light exclusion. Purification of the particles was performed by double centrifugation (AMICON Ultra-15 centrifugal filters, MWCO 3 kDa, 3,500 rpm, 45 min) in ultrapure water, followed by freeze-drying of the particles. The fluorescently labeled silica particles were freeze-dried with an alpha 2-4 LSC instrument (Christ).
Particle storage and treatment
The unfunctionalized particles were stored after synthesis at 4 °C in the dark under argon atmosphere. The PEI-labeled particles were freeze-dried after synthesis. Stock dispersions were prepared in water at a particle concentration of 1 g L−1. Before adding to the cell culture media, the stock dispersions were diluted to 5 to 80 mg L−1. Each dispersion was thoroughly vortexed after dilution and treated in an ultrasonic bath (Elma Sonic S10, 30 W, 50/60 Hz, 450 mL volume) for 5 min to obtain well-dispersed particles. All particle preparations were vortexed again immediately before application.
Cell culture
The biological characterization of the particles was performed with the cell line NR8383 (rat alveolar macrophages, LGC Standards GmbH, Wesel, Germany). The cells were cultivated with Ham's F-12 medium containing 15% fetal calf serum (FCS, GIBCO, Invitrogen, Karlsruhe, Germany) in 175 cm2 cell culture flasks (BD Falcon, Becton Dickinson GmbH, Heidelberg, Germany) at standard cell culture conditions (humidified atmosphere, 37 °C, 5% CO2). NR8383 cells were partly adherent and partly non-adherent. The ratio between adherent and non-adherent cells was about 1:1. For cell experiments, adherent cells were detached from the cell culture flasks with a TPP cell scraper (TPP Techno Plastic Products AG, Trasadingen, Switzerland), subsequently combined with non-adherent cells and seeded into 24-well cell culture plates (BD Falcon) at a concentration of 2.4 × 105 cells cm−2.
Particle uptake analyzed by FIB/SEM, TEM/EDX, and CLSM
We studied the uptake of silica particles by NR8383 cells by cross-sectional analysis of single cells, accomplished by focused ion beam milling (FIB) in combination with scanning electron microscopy (SEM), transmission electron microscopy (TEM), and energy-dispersive X-ray spectroscopy (EDX). After the fabrication of thin lamellae by FIB, the samples were imaged by TEM in combination with EDX for a detailed analysis.
To analyze the uptake of nanoparticles, NR8383 were exposed to 100 µg mL−1 of unfunctionalized silica particles for 24 h under cell culture conditions, detached from the culture plate as described above, and seeded on a titanium carrier plate (25 mm2). The cells were washed with PBS (GIBCO, Invitrogen) after 3 h of adherence under cell culture conditions and fixed with 3.7% glutaraldehyde (Sigma-Aldrich, Taufkirchen, Germany) in PBS (v/v). The cells were then washed again with PBS and dehydrated in an ascending ethanol row (50%, 70%, 90%, and 100%, 5 min each) according to standard procedures. After the dehydration step, the cell samples were mounted on SEM carriers and finally sputter-coated with 15 nm gold–palladium layer (K500X, Quorum Technologies Ltd., Ashford Kent, United Kingdom). Before the FIB milling, the samples were furthermore sputter-coated with a thin layer of carbon to protect the cells them from ion contamination and damage during the FIB procedure. The carbon layer was deposited with a gas injection system, delivering gaseous naphthalene that adsorbed to the sample surface. The naphthalene molecules were then decomposed by the electron or ion beam in a defined rectangular position. There, the beam was scanned over the sample surface. The deposited carbon layer remained on the surface, and gaseous decomposition products were removed by a vacuum pump.
Confocal laser scanning microscopy (CLSM) was used for detailed co-localization studies. The NR8383 cells were incubated with 100 µg mL−1 of PEI-FITC-labeled silica particles for 24 h under standard cell culture conditions and then stained with 50 nM of a specific endo/lysosomal fluorescent probe (LysoTracker Red DND-99, Invitrogen) in pure Ham’s F-12 medium for 30 min at 37 °C. The cells were analyzed by CLSM after three rinses with Ham’s F-12 medium.
Cytotoxicity assay
The cytotoxicity of silica particles was measured and quantified by flow cytometry. As positive control, silica nanoparticles were used (CAS No. 7631-86-9, Lot MKBF2889V, 99.5%, 10–20 nm) (Sigma-Aldrich, Steinheim, Germany). The particles were previously characterized in detail and consisted of agglomerated X-ray amorphous silica particles with a primary particle size of about 49 nm and an agglomerate size of about 2 µm36.
After 16 h of exposure to various silica concentrations (300, 200, 100, 50, 25 µg mL−1), adherent cells were detached from the cell culture plates with a TPP cell scraper, combined with non-adherent cells and transferred to 5 mL tubes (BD Biosciences). Non-viable cells were labeled with 50 µg mL−1 propidium iodide (PI, Sigma-Aldrich) for 10 min at room temperature, and the number of non-viable cells (PI positive) was analyzed by flow cytometry.
Generation of reactive oxygen species (ROS)
For the analysis of ROS formation induced by the exposure of NR8383 cells to silica particles, a DCF assay was performed by flow cytometry. The cells were incubated with different concentrations of silica particles (300, 200, 100 µg mL−1) for 2 h under cell culture conditions. A solution of 3% hydrogen peroxide (H2O2, Herbeta Arzneimittel, Berlin, Germany) served as positive control. The cells were incubated with 3% H2O2 for 30 min under cell culture conditions.
Subsequently, 20 µM of the cell-permeable ROS indicator 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA, Thermo Fisher Scientific, Waltham, USA) was added, and the cells were incubated at 37 °C for 30 min. The non-fluorescent H2DCFDA diffuses into cells, where it is deacetylated by intracellular esterases and converted to the highly fluorescent 2′,7′-dichlorofluorescein (DCF) form by oxidation. For discrimination between viable and non-viable cells, an additional PI staining was performed.
Protein microarray and ELISA
After incubation of NR8383 cells with different silica particles (100 µg mL−1) for 16 h, the supernatants were centrifuged at 300 g for 10 min and stored at -20 °C until the microarray analysis (Profiler Array Rat XL Cytokine Array Kit, Bio-Techne GmbH, Wiesbaden-Nordenstadt, Germany). The assay detected 79 different cytokines, growth factors and other mediators and enabled a semiquantitative analysis. The membrane-based sandwich immunoarray consists of a nitrocellulose membrane on which the captured antibodies are spotted as duplicated dots. Target proteins present in the sample bind to the capture antibodies and are detected with biotinylated detection antibodies and then visualized with chemiluminescent detection reagents. For analysis, the manufacturer's instructions were observed and chemiluminescence signals were detected and quantified by a microarray imager and the ImageQuantTL software (Amersham Imager 600 RGB, GE Healthcare Bio-Science, Uppsala, Sweden). For subsequent detailed analysis using Sandwich-ELISA Kits (R&D Systems Quantikine, Bio-Techne GmbH, Wiesbaden, Germany), 27 factors were selected based on the proteomic repertoire of NR8383 cells, as reported by Duhamel et al.58.
Particle induced cell migration assay (PICMA)
NR8383 cells were cultivated at 37 °C, 100% humidity, and 5% CO2 in Ham's F-12 + 15% FCS (fetal calf serum, Biochrom KG, Berlin, Germany), 2 mM L-glutamine, 100 µg mL−1 penicillin, and 100 U mL−1 streptomycin. Approximately 3 × 106 cells were seeded in 25 mL (175 cm2) medium.
HL-60 cells were obtained from DSMZ (Braunschweig, Germany). For the investigation of chemotaxis, we used trans-retinal differentiated HL-60 cells (dHL-60). The HL-60 cells were cultivated in RPMI 1640 medium (Biochrom KG) + 10% FSC, 2 mM L-glutamine, 100 µg mL−1 penicillin, 100 U mL−1 streptomycin, and 1 μM trans-retinoic acid at 37 °C, 100% humidity and 5% CO2 for three days64. In general, the dHL-60 cells grow adherent to standard culture dishes.
For the PICMA, NR8383 rat macrophages (3∙106 cells mL−1) were suspended with a vortex in 1 mL Ham's F-12 medium + 15% FCS, 2 mM L-glutamine, 100 µg mL−1 penicillin, and 100 U mL−1 streptomycin and seeded in 12.5 cm2 cell culture flasks at a final volume of 3 mL (2.4∙105 cells cm−2). The assay can also be performed in a smaller volume at constant surface volume ratio.
A sample in which cells without particles were incubated served as negative control. The subsequent experiments were repeated up to concentrations which gave the maximum induction of chemotaxis. Incubation of the NR8383 cells with the particles was performed at 37 °C, 100% humidity, and 5% CO2 for 16 h. Thereafter, the cells were removed by centrifugation with 300g for 5 min and the particles were removed by centrifugation with 15,000g for 10 min at room temperature. The supernatants were immediately used for the migration tests.
Cell migration was investigated according to Boyden65. with the modifications described by Westphal et al.36 and Schremmer et al.35, applying exclusively permanent cell lines: 200,000 unchallenged dHL-60 cells were added to 200 µL RPMI 1640 medium without FCS and seeded in each plate. A well insert (THINCERT, 3 µm pore size, Greiner bio-one, Frickenhausen, Germany) was placed into the cavities of 24 black well plates (Krystal, Dunn Labortechnik, Asbach, Germany). 500 µL of the supernatants of the particle-incubated NR8383 cells were added to the lower chamber. Migration of dHL-60 cells across the membrane was performed at 37 °C, 100% humidity, and 5% CO2 for 24 h. For calibration, 0 to 100,000 HL-60 cells were seeded directly into four-plate wells that were left without inserts.
Staining of migrated cells and of the calibration cells was performed with Calcein-AM for 60 min at 37 °C, 5% CO2, and 100% humidity by adding 500 µL Calcein-AM in the plate wells (> 90% HPLC, Sigma-Aldrich, Steinheim, Germany). Calcein-AM was delivered as 4 mM solution in DMSO, stored in aliquots at − 18 °C, and diluted to a final concentration of 4 µM in PBS.
The cell suspensions were removed from the plate wells and collected by centrifugation with 300 g for 5 min at room temperature. 850 µL of the supernatant were discarded while the cells were resuspended in the remaining volume of 150 µL. In addition, the adherent cells at the outside of the inserts were detached by adding 500 µL trypsin/EDTA (0.05%/0.02%, Biochrom) for 10 min at 37 °C, 5% CO2, and 100% humidity. Subsequently, the inserts were removed from the plate wells. Then, 150 µL of the collected cells were added into the plate wells that contained the 500 µL of the trypsin/EDTA-detached cells. The cell count was determined by fluorescence spectroscopy at 490/520 nm and calculated from the cell calibration (SpectraMax M3, Molecular Devices, Sunnyvale, USA).
Acceptance criteria for a valid test were positive (nanosized silica) and negative controls within the range of the established controls in our laboratory. A positive response was defined as a dose-dependent increase of cell migration of at least two consecutive concentrations with a maximum exceeding the base rate by at least two times at the highest concentration36.
The EC50 was calculated separately for each compound using nonlinear regression and the GraphPad Prism 8 software.
As reference, we used a silica reference sample (CAS No. 7631-86-9, Lot MKBF2889V, 99.5%, 10–20 nm) (Sigma-Aldrich, Steinheim, Germany). The particles were previously characterized in detail and consisted of agglomerated X-ray amorphous silica particles with a primary particle size of about 49 nm and an agglomerate size of about 2 µm36.
Statistical analysis
Data are expressed as the mean ± SD (n = 3) and given as the percentage of the control (cells not exposed to particles). For statistical evaluation, one-way analysis of variance (ANOVA) with Dunett's Multiple Comparison Test was applied using the GraphPad Prism software (GraphPad Software, Inc., CA, USA), while p values ≤ 0.05 were considered as statistically significant.
Acknowledgements
The use of FIB for the preparation of cross-sectional images at ZGH, RUB, is acknowledged.
Author contributions
M.K., M.O., N.R., K.L., M.B., A.R., and N.Z. performed the experiments, and contributed to experimental planning and design in collaboration with G.W., J.B., A.L., M.K., C.S., and M.E. M.K., M.O., N.R., K.L., M.B., A.R., and N.Z. performed the data analysis and statistics. G.W., J.B., M.K., C.S., and M.E. wrote the manuscript in collaboration with the other authors. All authors read and approved the final manuscript.
Funding
Open Access funding enabled and organized by Projekt DEAL. The authors acknowledge financial support of this work by the Deutsche Gesetzliche Unfallversicherung (DGUV, Project FP 412).
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Markus Kersting and Mateusz Olejnik.
Contributor Information
Christina Sengstock, Email: christina.sengstock@ruhr-uni-bochum.de.
Matthias Epple, Email: matthias.epple@uni-due.de.
References
- 1.Fruijtier-Polloth C. The toxicological mode of action and the safety of synthetic amorphous silica—a nanostructured material. Toxicology. 2012;294:61–79. doi: 10.1016/j.tox.2012.02.001. [DOI] [PubMed] [Google Scholar]
- 2.Barbé C, et al. Silica particles: a novel drug-delivery system. Adv. Mater. 2004;16:1959–1966. doi: 10.1002/adma.200400771. [DOI] [Google Scholar]
- 3.Li L, et al. In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. ACS Nano. 2010;4:6874–6882. doi: 10.1021/nn100918a. [DOI] [PubMed] [Google Scholar]
- 4.Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small. 2010;6:1952–1967. doi: 10.1002/smll.200901789. [DOI] [PubMed] [Google Scholar]
- 5.Singh P, Srivastava S, Singh SK. Nanosilica: Recent progress in synthesis, functionalization, biocompatibility, and biomedical applications. ACS Biomater. Sci. Eng. 2019;5:4882–4898. doi: 10.1021/acsbiomaterials.9b00464. [DOI] [PubMed] [Google Scholar]
- 6.Mohajerani A, et al. Nanoparticles in construction materials and other applications, and implications of nanoparticle use. Materials. 2019;12:3052. doi: 10.3390/ma12193052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Aula S, et al. Biophysical, biopharmaceutical and toxicological significance of biomedical nanoparticles. RSC Adv. 2015;5:47830–47859. doi: 10.1039/C5RA05889A. [DOI] [Google Scholar]
- 8.Jaganathan H, Godin B. Biocompatibility assessment of Si-based nano- and micro-particles. Adv. Drug Deliv. Rev. 2012;64:1800–1819. doi: 10.1016/j.addr.2012.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Tang L, Cheng JJ. Nonporous silica nanoparticles for nanomedicine application. Nano Today. 2013;8:290–312. doi: 10.1016/j.nantod.2013.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Jain P, et al. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link? Biotechnol. Adv. 2017;35:889–904. doi: 10.1016/j.biotechadv.2017.08.003. [DOI] [PubMed] [Google Scholar]
- 11.David CAW, Owen A, Liptrott NJ. Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches. Nanomedicine. 2016;11:1447–1464. doi: 10.2217/nnm-2016-0017. [DOI] [PubMed] [Google Scholar]
- 12.Shin SW, Song IH, Um SH. Role of physicochemical properties in nanoparticle toxicity. Nanomaterials. 2015;5:1351–1365. doi: 10.3390/nano5031351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Bruinink A, Wang J, Wick P. Effect of particle agglomeration in nanotoxicology. Arch. Toxicol. 2015;89:659–675. doi: 10.1007/s00204-015-1460-6. [DOI] [PubMed] [Google Scholar]
- 14.Cheng LC, Jiang XM, Wang J, Chen CY, Liu RS. Nano-bio effects: interaction of nanomaterials with cells. Nanoscale. 2013;5:3547–3569. doi: 10.1039/c3nr34276j. [DOI] [PubMed] [Google Scholar]
- 15.Kelly PM, et al. Mapping protein binding sites on the biomolecular corona of nanoparticles. Nat. Nanotechnol. 2015;10:472–479. doi: 10.1038/nnano.2015.47. [DOI] [PubMed] [Google Scholar]
- 16.Monopoli MP, et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011;133:2525–2534. doi: 10.1021/ja107583h. [DOI] [PubMed] [Google Scholar]
- 17.Pelaz B, et al. Diverse applications of nanomedicine. ACS Nano. 2017;11:2313–2381. doi: 10.1021/acsnano.6b06040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Fruijtier-Pölloth C. The safety of nanostructured synthetic amorphous silica (SAS) as a food additive (E 551) Arch. Toxicol. 2016;90:2885–2916. doi: 10.1007/s00204-016-1850-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.IARC. IARC working group on the evaluation of carcinogenic risks to humans: silica, some silicates, coal dust and para-aramid fibrils. IARC Monogr. Eval. Carcinog. Risks Hum.68, 1–475 (1997). [PMC free article] [PubMed]
- 20.Sato T, Shimosato T, Klinman DM. Silicosis and lung cancer: current perspectives. Lung Cancer Targets Ther. 2018;9:91–101. doi: 10.2147/LCTT.S156376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Borm PJA, Fowler P, Kirkland D. An updated review of the genotoxicity of respirable crystalline silica. Part. Fibre Toxicol. 2018;15:23. doi: 10.1186/s12989-018-0259-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kawasaki H. A mechanistic review of silica-induced inhalation toxicity. Inhal. Toxicol. 2015;27:363–377. doi: 10.3109/08958378.2015.1066905. [DOI] [PubMed] [Google Scholar]
- 23.Nakayama M. Macrophage recognition of crystals and nanoparticles. Front. Immunol. 2018;9:103. doi: 10.3389/fimmu.2018.00103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Oberdörster G. Lung particle overload: implications for occupational exposures to particles. Regul. Toxicol. Pharmacol. 1995;21:123–135. doi: 10.1006/rtph.1995.1017. [DOI] [PubMed] [Google Scholar]
- 25.Oberdörster G. Pulmonary effects of inhaled ultrafine particles. Int. Arch. Occup. Environ. Health. 2001;74:1–8. doi: 10.1007/s004200000185. [DOI] [PubMed] [Google Scholar]
- 26.Shu F, Shi Y. Systematic overview of solid particles and their host responses. Front. Immunol. 2018;9:1157. doi: 10.3389/fimmu.2018.01157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Chen LJ, et al. The toxicity of silica nanoparticles to the immune system. Nanomedicine. 2018;13:1939–1962. doi: 10.2217/nnm-2018-0076. [DOI] [PubMed] [Google Scholar]
- 28.Landsiedel R, Sauer UG, Ma-Hock L, Schnekenburger J, Wiemann M. Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies. Nanomedicine. 2014;9:2557–2585. doi: 10.2217/nnm.14.149. [DOI] [PubMed] [Google Scholar]
- 29.Yazdimamaghani M, Moos PJ, Dobrovolskaia MA, Ghandehari H. Genotoxicity of amorphous silica nanoparticles: Status and prospects. Nanomed. Nanotechnol. Biol. Med. 2019;16:106–125. doi: 10.1016/j.nano.2018.11.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Landsiedel R, et al. Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials. Part. Fibre Toxicol. 2014;11:16. doi: 10.1186/1743-8977-11-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Skuland T, et al. Pro-inflammatory effects of crystalline- and nano-sized non-crystalline silica particles in a 3D alveolar model. Part. Fibre Toxicol. 2020;17:13. doi: 10.1186/s12989-020-00345-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Wiemann M, et al. An in vitro alveolar macrophage assay for predicting the short-term inhalation toxicity of nanomaterials. J. Nanobiotechnol. 2016;14:16. doi: 10.1186/s12951-016-0164-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Hsiao IL, et al. Size and cell type dependent uptake of silica nanoparticles. J. Nanomed. Nanotechnol. 2014;5:1000248. [Google Scholar]
- 34.Loza K, et al. Barium sulfate micro- and nanoparticles as bioinert reference material in particle toxicology. Nanotoxicology. 2016;10:1492–1502. doi: 10.1080/17435390.2016.1235740. [DOI] [PubMed] [Google Scholar]
- 35.Schremmer I, et al. Kinetics of chemotaxis, cytokine and chemokine release of NR8383 macrophages after exposure to inflammatory and inert granular insoluble particles. Toxicol. Lett. 2016;263:68–75. doi: 10.1016/j.toxlet.2016.08.014. [DOI] [PubMed] [Google Scholar]
- 36.Westphal GA, et al. Particle-induced cell migration assay (PICMA): A new in vitro assay for inflammatory particle effects based on permanent cell lines. Toxicol. In Vitro. 2015;29:997–1005. doi: 10.1016/j.tiv.2015.04.005. [DOI] [PubMed] [Google Scholar]
- 37.Stöber W, Fink A, Bohn E. Controlled growth of monodisperse silica spheres in the micron size range. J. Colloid Interface Sci. 1968;26:62–69. doi: 10.1016/0021-9797(68)90272-5. [DOI] [Google Scholar]
- 38.Huang XL, Teng X, Chen D, Tang FQ, He JQ. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials. 2010;31:438–448. doi: 10.1016/j.biomaterials.2009.09.060. [DOI] [PubMed] [Google Scholar]
- 39.Jung HS, Moon DS, Lee JK. Quantitative analysis and efficient surface modification of silica nanoparticles. J. Nanomater. 2012;2012:593471. [Google Scholar]
- 40.Nozawa K, et al. Smart control of monodisperse Stoeber silica particles: effect of reactant addition rate on growth process. Langmuir. 2005;21:1516–1523. doi: 10.1021/la048569r. [DOI] [PubMed] [Google Scholar]
- 41.Bellamy LJ. The Infra-red Spectra of Complex Molecules. London: Chapman and Hall; 1975. [Google Scholar]
- 42.Feliu N, Sun X, Alvarez Puebla RA, Parak WJ. Quantitative particle–cell interaction: some basic physicochemical pitfalls. Langmuir. 2017;33:6639–6646. doi: 10.1021/acs.langmuir.6b04629. [DOI] [PubMed] [Google Scholar]
- 43.Nazarenus M, et al. In vitro interaction of colloidal nanoparticles with mammalian cells: What have we learned thus far? Beilstein J. Nanotechnol. 2014;5:1477–1490. doi: 10.3762/bjnano.5.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Hinderliter PM, et al. ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part. Fibre Toxicol. 2010;7:1–20. doi: 10.1186/1743-8977-7-36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Behzadi S, et al. Cellular uptake of nanoparticles: journey inside the cell. Chem. Soc. Rev. 2017;46:4218–4244. doi: 10.1039/C6CS00636A. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Greulich C, et al. Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater. 2011;7:347–354. doi: 10.1016/j.actbio.2010.08.003. [DOI] [PubMed] [Google Scholar]
- 47.Beddoes CM, Case CP, Briscoe WH. Understanding nanoparticle cellular entry: a physicochemical perspective. Adv. Coll. Interface Sci. 2015;218:48–68. doi: 10.1016/j.cis.2015.01.007. [DOI] [PubMed] [Google Scholar]
- 48.Kuhn DA, et al. Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages. Beilstein J. Nanotechnol. 2014;5:1625–1636. doi: 10.3762/bjnano.5.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Dykman LA, Khlebtsov NG. Uptake of engineered gold nanoparticles into mammalian cells. Chem. Rev. 2014;114:1258–1288. doi: 10.1021/cr300441a. [DOI] [PubMed] [Google Scholar]
- 50.Iversen TG, Skotland T, Sandvig K. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today. 2011;6:176–185. doi: 10.1016/j.nantod.2011.02.003. [DOI] [Google Scholar]
- 51.Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J. Control. Release. 2010;145:182–195. doi: 10.1016/j.jconrel.2010.01.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Gil PR, Nazarenus M, Ashraf S, Parak WJ. pH-sensitive capsules as intracellular optical reporters for monitoring lysosomal pH changes upon stimulation. Small. 2012;8:943–948. doi: 10.1002/smll.201101780. [DOI] [PubMed] [Google Scholar]
- 53.Messerschmidt C, et al. On the pathway of cellular uptake: new insight into the interaction between the cell membrane and very small nanoparticles. Beilstein J. Nanotechnol. 2016;7:1296–1311. doi: 10.3762/bjnano.7.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Herd H, et al. Nanoparticle geometry and surface orientation influence mode of cellular uptake. ACS Nano. 2013;7:1961–1973. doi: 10.1021/nn304439f. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Sokolova V, et al. A systematic electron microscopic study on the uptake of barium sulphate nano-, submicro-, microparticles by bone marrow-derived phagocytosing cells. Acta Biomater. 2018;80:352–363. doi: 10.1016/j.actbio.2018.09.026. [DOI] [PubMed] [Google Scholar]
- 56.Patel S, et al. Brief update on endocytosis of nanomedicines. Adv. Drug Deliv. Rev. 2019;144:90–111. doi: 10.1016/j.addr.2019.08.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Kollenda S, et al. A pH-sensitive fluorescent protein sensor to follow the pathway of calcium phosphate nanoparticles into cells. Acta Biomater. 2020;111:406–417. doi: 10.1016/j.actbio.2020.05.014. [DOI] [PubMed] [Google Scholar]
- 58.Duhamel M, et al. Molecular consequences of proprotein convertase 1/3 (PC1/3) inhibition in macrophages for application to cancer immunotherapy: A proteomic study. Mol. Cell. Proteom. 2015;14:2857–2877. doi: 10.1074/mcp.M115.052480. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Waters KM, et al. Macrophage responses to silica nanoparticles are highly conserved across particle sizes. Toxicol. Sci. 2009;107:553–569. doi: 10.1093/toxsci/kfn250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Pauluhn J. Poorly soluble particulates: searching for a unifying denominator of nanoparticles and fine particles for DNEL estimation. Toxicology. 2011;279:176–188. doi: 10.1016/j.tox.2010.10.009. [DOI] [PubMed] [Google Scholar]
- 61.Pauluhn J. Derivation of occupational exposure levels (OELs) of low-toxicity isometric biopersistent particles: how can the kinetic lung overload paradigm be used for improved inhalation toxicity study design and OEL-derivation? Part. Fibre Toxicol. 2014;11:72. doi: 10.1186/s12989-014-0072-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Li Y, Boraschi D. Endotoxin contamination: a key element in the interpretation of nanosafety studies. Nanomedicine. 2016;11:269–287. doi: 10.2217/nnm.15.196. [DOI] [PubMed] [Google Scholar]
- 63.Yu T, Malugin A, Ghandehari H. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano. 2011;5:5717–5728. doi: 10.1021/nn2013904. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA. 1980;77:2936–2940. doi: 10.1073/pnas.77.5.2936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J. Exp. Med. 1962;115:453–466. doi: 10.1084/jem.115.3.453. [DOI] [PMC free article] [PubMed] [Google Scholar]